<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.2" -->
<rss version="0.92">
<channel>
	<title>Pharmaceutical Rep Overtime Compensation</title>
	<link>http://pharmarepovertime.com</link>
	<description>Kingsley &#38; Kingsley, APC (888) 500-8469</description>
	<lastBuildDate>Fri, 03 Feb 2012 19:31:17 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Supreme Court Set Argument</title>
		<description><![CDATA[It&#8217;s official, Christopher v. Smithkline Beechum will be heard on April 16, 2012.  It is the only matter on the calendar for the day and the argument will last one hour.  On Monday all of the amicus for the petitioners will file their briefs.  Four briefs will be filed in support of the reps including the United [...]]]></description>
		<link>http://pharmarepovertime.com/2012/02/03/supreme-court-set-argument-in-christopher/</link>
			</item>
	<item>
		<title>Opening Brief Filed in Supreme Court on Christopher</title>
		<description><![CDATA[The opening brief was filed in the United States Supreme Court in Christopher v. Smithkline Beecham.  Kingsley &#38; Kingsley appears as one of four counsel on the brief.  Counsel of Record Thomas Goldstein took the lead in editing and finalizing the brief and will be arguing the case in front of the court in April.  [...]]]></description>
		<link>http://pharmarepovertime.com/2012/01/30/opening-brief-filed-in-supreme-court-on-christopher/</link>
			</item>
	<item>
		<title>Warner Chilcot Sued for Unpaid Overtime</title>
		<description><![CDATA[Today, Warner Chilcot was sued by Joseph, Herzfeld, Hester &#38; Kirschenbaum and Kingsley &#38; Kingsley for unpaid overtime in the state of New York.  In light of the Novartis settlement for $99m we expect to see a flurry of filing in the next few weeks.  If you need legal assistance and you are a pharmaceutical representative [...]]]></description>
		<link>http://pharmarepovertime.com/2012/01/30/warner-chilcot-sued-for-unpaid-overtime/</link>
			</item>
	<item>
		<title>News Reports on Novartis Settlement</title>
		<description><![CDATA[Wall Street Journal on Novartis
Associated Press on Novartis
Washington Post
FOX Business
]]></description>
		<link>http://pharmarepovertime.com/2012/01/25/the-wall-street-journal-reports-on-novartis/</link>
			</item>
	<item>
		<title>Novartis Settles claims for $99m</title>
		<description><![CDATA[Last night it was reported that Novartis has settled its claims against the reps for a reported $99,000,000.00.  My understanding is this will include all reps who opted in to the case previously and reps who worked in New York and California.  This would represent the first major settlement of a pharmaceutical overtime case.  It [...]]]></description>
		<link>http://pharmarepovertime.com/2012/01/25/novartis-settles-claims-for-99m/</link>
			</item>
	<item>
		<title>The Deference Trend in the Supreme Court</title>
		<description><![CDATA[Scotusblog had an interesting article about the deference jurisprudence in the United States Supreme Court.  Ms. Frost seemed to indicated that Christopher v. Smithkline Beecham was the case for the court to reconsider Auer.  Scalia seemed to suggest as much in Talk America last term.  This is a bit inside baseball, but the primary concern [...]]]></description>
		<link>http://pharmarepovertime.com/2012/01/25/the-deference-trend-in-the-suprme-court/</link>
			</item>
	<item>
		<title>CA Supreme Court Decides Harris</title>
		<description><![CDATA[This morning the CA Supreme Court issued its decision in Harris v. Superior Court.  This case has relevance because the Bayer, Wyeth and Roche cases in the 9th Cir. were stayed pending Harris.  By January 18th further briefs will be filed in the 9th determining the impact of Harris.  The Court overruled the plaintiff&#8217;s motions [...]]]></description>
		<link>http://pharmarepovertime.com/2011/12/29/ca-supreme-court-decides-harris/</link>
			</item>
	<item>
		<title>Tom Goldstein to Argue GSK</title>
		<description><![CDATA[Thomas C. Goldstein of Goldstein &#38; Russell has been retained by a group of lawyers handling the pharmaceutical litigation to brief and argue the case before the United States Supreme Court.  He is the editor and founder of Scotusblog which monitors and catalogs all activities before the Supreme Court.  He will be arguing his 27th [...]]]></description>
		<link>http://pharmarepovertime.com/2011/12/28/tom-goldstein-to-argue-gsk/</link>
			</item>
	<item>
		<title>SCOTUS Agrees to Hear GSK</title>
		<description><![CDATA[This morning, the Supreme Court of the United States granted certiorari in the case of Christopher v. Smithkline Beechman regarding the issue of the outside sales exemption in the pharmaceutical industry. This means the high court will decide the issue once and for all and resolve the Circuit split between the 9th and the 2nd. [...]]]></description>
		<link>http://pharmarepovertime.com/2011/11/28/scotus-agrees-to-hear-gsk/</link>
			</item>
	<item>
		<title>Conference date set for GSK</title>
		<description><![CDATA[On November 22 , the United States Supreme Court will meet in conference to determine if Christopher v. Smithkline Beecham 635 F.3d 383 (9th Cir. 2011) will be heard by the court.  Their decision will be released on November 28th here.  For a case to be heard, only four justices are needed to vote in favor [...]]]></description>
		<link>http://pharmarepovertime.com/2011/11/01/scotus-set-conference-date-for-gsk/</link>
			</item>
</channel>
</rss>

